Patents by Inventor Hamid A. Boulares

Hamid A. Boulares has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARP-1 and methods of use thereof
    Patent number: 11723906
    Abstract: The invention is directed to roles for PARP-1 in disease.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: August 15, 2023
    Assignee: The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Hamid Boulares, Mohamed Ghonim, Amir Al-Khami, Augusto Ochoa
  • PARP-1 AND METHODS OF USE THEREOF
    Publication number: 20200230134
    Abstract: The invention is directed to roles for low doses of PARP-1 inhibitors and synergistic combinations thereof to treat disease.
    Type: Application
    Filed: January 14, 2020
    Publication date: July 23, 2020
    Inventors: Hamid Boulares, Mohamed Ghonim
  • PARP-1 AND METHODS OF USE THEREOF
    Publication number: 20200069682
    Abstract: The invention is directed to roles for PARP-1 in disease.
    Type: Application
    Filed: September 9, 2019
    Publication date: March 5, 2020
    Inventors: Hamid Boulares, Mohamed Ghonim, Amir Al-Khami, Augusto Ochoa
  • Regression of Established Atherosclerotic Plaques, and Treating Sudden-Onset Asthma Attacks, using PARP Inhibitors
    Publication number: 20110028420
    Abstract: A method is disclosed for treating and inducing the regression of established atherosclerotic plaques. A method is disclosed for treating asthma, including treatment of an ongoing asthma attack. In both cases, treatment with PARP inhibitors, such as the PARP inhibitor TIQ-A (Thieno[2,3-c]isoquinolin-5-one), can lead to regression of existing disease and symptoms.
    Type: Application
    Filed: April 7, 2009
    Publication date: February 3, 2011
    Inventors: Hamid A. Boulares, Chetan P. Hans, Amarjit S. Naura